Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enhanced Cardiology Associates is a specialized healthcare provider focused on non-invasive cardiovascular treatments, particularly Enhanced External Counterpulsation (EECP) therapy. The practice serves patients with chronic stable angina, congestive heart failure, and other cardiovascular conditions that may not have responded well to traditional surgical or pharmacological interventions. By utilizing advanced external counterpulsation technology, the clinic aims to improve blood flow and reduce cardiac workload without the need for invasive procedures. Their services are designed to enhance the quality of life for patients with debilitating heart conditions through evidence-based, non-surgical protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enhanced Cardiology Associates.